Atrial Fibrillation Devices Global Market Report 2025
상품코드:1810835
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
심방세동 기기 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 연평균 성장률(CAGR) 11.5%로 132억 8,000만 달러로 성장할 것입니다. 예측 기간 동안의 성장은 의료비 지출 증가, 다학제 전문 병원 증가, 첨단 치료 옵션의 채택 확대, 규제 당국의 기기 승인에 대한 지원 강화, 최소침습 수술에 대한 수요 증가에 기인합니다. 예측 기간 동안 예상되는 주요 동향으로는 기술 발전, 원격 모니터링 장비의 발전, 진단 프로세스에 인공지능의 통합, 최소침습적 절제 시스템의 혁신, 매핑 및 영상 기술의 개선 등이 있습니다.
심혈관질환에 대한 부담 증가는 향후 몇 년 동안 심방세동 기기 시장의 성장을 촉진할 것으로 예상됩니다. 심혈관질환에는 심장마비, 뇌졸중, 고혈압 등 심장과 혈관에 영향을 미치는 질환이 포함됩니다. 이러한 질병의 유병률 증가는 전 세계적으로 비만과 당뇨병의 증가와 더불어 앉아서 생활하는 습관과 건강에 해로운 식습관이 주요 원인으로 작용하고 있습니다. 심방세동(AFib) 기기는 심장의 기저질환과 관련이 있는 부정맥을 감지, 모니터링, 치료함으로써 심혈관질환을 관리하는 데 필수적입니다. 예를 들어, 2024년 6월 미국 공중보건단체인 미국심장협회는 고혈압 유병률이 51.2%에서 61.0%로 증가하고, 심혈관질환 진단을 받는 인구가 2020년 1억 2,800만 명에서 2050년 1억 8,400만 명 이상으로 늘어날 것으로 예측했습니다. 이처럼 심혈관질환 유병률의 증가는 심방세동 기기 시장의 확대에 기여하고 있습니다.
심방세동 기기 시장의 주요 업체들은 진단 정확도 향상, 치료 전략 맞춤화, 환자 결과 개선을 위한 환자 중심 임상 의사결정 지원 도구 등 기술 발전에 주력하고 있습니다. 이러한 도구는 개별 환자 데이터를 분석하여 보다 개인화된 치료 결정을 내릴 수 있도록 의료 서비스 제공자를 지원하도록 설계된 디지털 시스템입니다. 예를 들어, 2023년 8월 미국의 의료 기술 기업 GE헬스케어 테크놀러지스는 심방세동 환자의 워크플로우를 간소화하고, 심방세동 환자를 위한 맞춤형 치료를 지원하기 위해 만들어진 디지털 임상 의사결정 지원 도구인 심방세동용 CardioVisio를 발표하였습니다. 이 도구는 심방세동의 진행을 시각화하는 데 도움이 되며, 과거 진단, 치료, 투약, 관련 질환을 통합할 수 있습니다. 또한, 확립된 가이드라인에 기반한 치료법 추천을 제공함으로써 진단 오류의 가능성을 줄이고, 보다 효율적인 임상적 의사결정을 촉진합니다. CardioVisio는 흩어져 있는 환자 데이터를 접근 가능한 형태로 통합하여 의료진이 심방세동을 보다 효과적이고 효율적으로 관리할 수 있도록 돕습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 심방세동 기기 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 심방세동 기기 시장 : 성장률 분석
세계의 심방세동 기기 시장 실적 : 규모와 성장, 2019-2024
세계의 심방세동 기기 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 심방세동 기기 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 심방세동 기기 시장 : 기기 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
이식형 기기
외부 기기
카테터 기반 기기
세계의 심방세동 기기 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
전기생리학 절제 카테터
심장 모니터 또는 이식형 루프 레코더
전기생리학 진단 카테터
매핑 및 기록 시스템
액세스 기기
심장 내심 에코 검사
좌심방이 폐쇄 기기
기타 제품
세계의 심방세동 기기 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
무선 주파수
냉동요법
초음파
기타 기술
세계의 심방세동 기기 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
직접 판매
판매대리점
온라인 판매
세계의 심방세동 기기 시장 : 최종 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
심장 센터
외래 수술 센터
기타 최종사용자
세계의 심방세동 기기 시장 : 하위 세분화 이식형 기기(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
이식형 제세동기
페이스메이커
삽입형 심장 모니터
세계의 심방세동 기기 시장 : 하위 세분화 외부 기기(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
체외식 제세동기
홀터 모니터
모바일 심장 텔레메트리 기기
심전도 모니터
세계의 심방세동 기기 시장 : 하위 세분화 카테터 기반 기기(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
고주파 절제 카테터
동결 절제 카테터
레이저 절제 카테터
매핑과 내비게이션 시스템
경중격 액세스 기기
제7장 지역별·국가별 분석
세계의 심방세동 기기 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 심방세동 기기 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
심방세동 기기 시장 : 경쟁 구도
심방세동 기기 시장 : 기업 개요
Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Medtronic Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Shanghai MicroPort EP MedTech Co. Ltd.
Japan Lifeline Co. Ltd.
Microlife Corporation
AliveCor Inc.
CardioFocus Inc.
Imricor Medical Systems Inc.
Kardium Inc.
Stereotaxis Inc.
Volta Medical
Synaptic Medical Corporation
Osypka AG
CathRx Ltd.
BIOTRONIK SE & Co. KG
EP Solutions SA
CardiacSense Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
심방세동 기기 시장 2029 : 새로운 기회를 제공하는 국가
심방세동 기기 시장 2029 : 새로운 기회를 제공하는 부문
심방세동 기기 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Atrial fibrillation (AFib) devices are medical technologies developed to detect, monitor, or treat atrial fibrillation, a prevalent heart rhythm disorder characterized by irregular beating of the heart's upper chambers. These devices include implantable cardiac monitors, pacemakers, defibrillators, catheter ablation systems, and wearable electrocardiogram (ECG) monitors. The primary objective of AFib devices is to restore normal heart rhythm, minimize stroke risk, and enhance quality of life.
The main types of atrial fibrillation devices include implantable devices, external devices, and catheter-based devices. Implantable devices refer to tools such as pacemakers, implantable cardioverter defibrillators (ICDs), and implantable loop recorders, which are surgically placed within the body to monitor, regulate, or correct heart rhythm by delivering electrical impulses or continuously recording cardiac activity. These devices are used across various applications, including electrophysiology ablation catheters, cardiac monitors or implantable loop recorders, electrophysiology diagnostic catheters, mapping and recording systems, access devices, intracardiac echocardiography, left atrial appendage closure devices, and other related tools. They operate using technologies such as radiofrequency, cryotherapy, ultrasound, and other advanced methods. Distribution channels include direct sales, distributors, and online platforms, serving end users such as hospitals, cardiac centers, ambulatory surgical centers, and other healthcare providers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The atrial fibrillation devices market research report is one of a series of new reports from The Business Research Company that provides atrial fibrillation devices market statistics, including atrial fibrillation devices industry global market size, regional shares, competitors with a atrial fibrillation devices market share, detailed atrial fibrillation devices market segments, market trends and opportunities, and any further data you may need to thrive in the atrial fibrillation devices industry. This atrial fibrillation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The atrial fibrillation devices market size has grown rapidly in recent years. It will grow from $7.69 billion in 2024 to $8.60 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth during the historic period can be attributed to an increase in the aging population, rising demand for minimally invasive cardiac procedures, expansion of government initiatives, and greater availability of telecardiology services.
The atrial fibrillation devices market size is expected to see rapid growth in the next few years. It will grow to $13.28 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth during the forecast period can be attributed to rising healthcare expenditure, an increasing number of multi-specialty hospitals, greater adoption of advanced treatment options, enhanced regulatory support for device approvals, and growing demand for minimally invasive surgical procedures. Key trends anticipated in the forecast period include technological advancements, progress in remote monitoring devices, integration of artificial intelligence in diagnostic processes, innovations in minimally invasive ablation systems, and improvements in mapping and imaging technologies.
The increasing burden of cardiovascular diseases is expected to drive the growth of the atrial fibrillation device market in the coming years. Cardiovascular diseases encompass conditions that affect the heart and blood vessels, such as heart attacks, strokes, and hypertension. The growing prevalence of these conditions is largely attributed to rising global rates of obesity and diabetes, combined with sedentary lifestyles and unhealthy eating habits. Atrial fibrillation (AFib) devices are essential for managing cardiovascular diseases by detecting, monitoring, and treating irregular heart rhythms, which are frequently linked to underlying heart problems. For example, in June 2024, the American Heart Association, a US-based public health organization, reported that as the prevalence of high blood pressure is projected to increase from 51.2% to 61.0%, the number of individuals diagnosed with cardiovascular diseases is expected to grow from 128 million in 2020 to over 184 million by 2050. Thus, the rising incidence of cardiovascular diseases is contributing to the expansion of the atrial fibrillation device market.
Key players in the atrial fibrillation devices market are focusing on technological advancements, such as patient-centric clinical decision support tools, to improve diagnostic accuracy, customize treatment strategies, and enhance patient outcomes. These tools are digital systems designed to assist healthcare providers by analyzing individual patient data to inform more personalized care decisions. For instance, in August 2023, GE HealthCare Technologies Inc., a US-based medical technology company, introduced CardioVisio for Atrial Fibrillation, a digital clinical decision support tool created to streamline clinician workflows and support targeted care for AFib patients. The tool helps visualize AFib progression, incorporating previous diagnoses, treatments, medications, and related conditions. It also provides therapy recommendations based on established guidelines, reducing the likelihood of diagnostic errors and facilitating more efficient clinical decision-making. CardioVisio consolidates scattered patient data into an accessible format, helping medical professionals manage atrial fibrillation more effectively and efficiently.
In November 2023, Johnson & Johnson MedTech, a US-based medical technology firm, acquired Laminar Inc. for an undisclosed amount. This acquisition aims to enhance Johnson & Johnson MedTech's position in the atrial fibrillation device sector and broaden its range of solutions focused on stroke prevention and cardiac care. Laminar Inc. is a US-based company specializing in the development of innovative devices for left atrial appendage elimination, which are used to prevent strokes in patients with atrial fibrillation.
Major players in the atrial fibrillation devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Public Limited Company, Koninklijke Philips N.V., Boston Scientific Corporation, Shanghai MicroPort EP MedTech Co. Ltd., Japan Lifeline Co. Ltd., Microlife Corporation, AliveCor Inc., CardioFocus Inc., Imricor Medical Systems Inc., Kardium Inc., Stereotaxis Inc., Volta Medical, Synaptic Medical Corporation, Osypka AG, CathRx Ltd., BIOTRONIK SE & Co. KG, EP Solutions SA, CardiacSense Ltd.
North America was the largest region in the atrial fibrillation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in atrial fibrillation devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the atrial fibrillation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The atrial fibrillation devices market consists of revenues earned by entities providing services such as diagnostic services, therapeutic services, and patient monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The atrial fibrillation devices market also includes sales of cryoablation catheters, laser ablation systems, and hybrid ablation systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Atrial Fibrillation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on atrial fibrillation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for atrial fibrillation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The atrial fibrillation devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Atrial Fibrillation Devices Market Trends And Strategies
4. Atrial Fibrillation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Atrial Fibrillation Devices Growth Analysis And Strategic Analysis Framework
5.1. Global Atrial Fibrillation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Atrial Fibrillation Devices Market Growth Rate Analysis
5.4. Global Atrial Fibrillation Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Atrial Fibrillation Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Atrial Fibrillation Devices Total Addressable Market (TAM)
6.1. Global Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Implantable Devices
External Devices
Catheter-Based Devices
6.2. Global Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electrophysiology Ablation Catheters
Cardiac Monitors Or Implantable Loop Recorder
Electrophysiology Diagnostic Catheters
Mapping And Recording Systems
Access Devices
Intracardiac Echocardiography
Left Atrial Appendage Closure Devices
Other Products
6.3. Global Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Radiofrequency
Cryotherapy
Ultrasound
Other Technologies
6.4. Global Atrial Fibrillation Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Direct Sales
Distributors
Online Sales
6.5. Global Atrial Fibrillation Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Other End Users
6.6. Global Atrial Fibrillation Devices Market, Sub-Segmentation Of Implantable Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Implantable Cardioverter Defibrillators
Pacemakers
Insertable Cardiac Monitors
6.7. Global Atrial Fibrillation Devices Market, Sub-Segmentation Of External Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
External Defibrillators
Holter Monitors
Mobile Cardiac Telemetry Devices
Electrocardiogram Monitors
6.8. Global Atrial Fibrillation Devices Market, Sub-Segmentation Of Catheter-Based Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Radiofrequency Ablation Catheters
Cryoablation Catheters
Laser Ablation Catheters
Mapping And Navigation Systems
Transseptal Access Devices
7. Atrial Fibrillation Devices Market Regional And Country Analysis
7.1. Global Atrial Fibrillation Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Atrial Fibrillation Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
